Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MYGN will decline by -10.00% over the next 2 Weeks and hit $4.56 by Monday, February 23, 2026. In that time frame, MYGN's share price is expected to range between $4.33 and $4.79.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 23, 2026 | 4.33 | 4.56 | 4.79 |
| Feb 20, 2026 | 4.37 | 4.61 | 4.84 |
| Feb 19, 2026 | 4.46 | 4.69 | 4.92 |
| Feb 18, 2026 | 4.51 | 4.73 | 4.95 |
| Feb 17, 2026 | 4.48 | 4.71 | 4.93 |
| Feb 16, 2026 | 4.58 | 4.82 | 5.06 |
| Feb 13, 2026 | 4.63 | 4.86 | 5.09 |
| Feb 12, 2026 | 4.72 | 4.94 | 5.16 |
| Feb 11, 2026 | 4.74 | 4.98 | 5.20 |
| Feb 10, 2026 | 4.75 | 4.97 | 5.20 |
MYGN shares rose +0.20% in Tuesday, February 10, 2026's trading session, rising from a previous close of $5.07 to move at $5.08. The stock demonstrated notable intraday movement (see MYGN's key stats for a full breakdown), fluctuating between $5.05 and $5.29, a +4.75% trading range. While recent weeks have seen some volatility, MYGN has managed to secure a -11.19% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 830.24K shares changing hands, 146.48K fewer than the previous session. This amounted to $4.22M in total market activity.
Will MYGN Continue Its Downward Trend?
According to analyst ratings and projections for MYGN, Myriad Genetics, Inc. shares are anticipated to decrease by -6.16%, potentially reaching $4.79 per share by February 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for MYGN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 9 positive trading days within the past 30 sessions. Based on the MYGN stock forecast, now is not the best time to buy MYGN stock because its current trading price is +11.34% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MYGN covering social and institutional perspectives.
MYGN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MYGN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 23.21% to 31.61%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 41.21%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.72%, maintains a neutral outlook for the long term. Insights into MYGN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Myriad Genetics Short-Term Forecasts
MYGN Forecast For Next 5 Days
Our algorithm anticipates Myriad Genetics (MYGN) stock could hit $4.23 by Feb 17, 2026. This represents a -16.75% fall from today's price, following a -13.55% change over the past five days.
MYGN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Myriad Genetics, Inc. (MYGN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.29, which would mean a -15.55% decrease from the current price of $5.08. Projections for this period range from a high of $5.09 to a low of $3.48.
MYGN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Myriad Genetics's price over the next three months point to a rise. MYGN stock is expected to peak at $11.85 on Mar 17, 2026 before potentially dipping to $6.57 on Apr 21, 2026. On average, MYGN is likely to trade around $9.35 in the coming 90 days.
Myriad Genetics Stock Forecast 2025
Based on our predictive models, Myriad Genetics (MYGN) is expected to trade between $2.20 and $24.03 throughout 2026. This would result in an average price of $13.20, potentially offering investors a +159.84% return from current levels.
Myriad Genetics, Inc. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Myriad Genetics, Inc. (MYGN) is positioned to show a strong performance in February 2026. The price is predicted to move between $8.37 and $10.61, settling at an average of $9.56. This could translate to a +88.19% gain.
March 2026
Based on current market signals, Myriad Genetics, Inc. is projected to trend march 2026. We forecast a trading range from $8.99 to $11.85, with a likely average price of $10.80. Investors could expect a potential return of +112.60%.
April 2026
Our predictive algorithms indicate Myriad Genetics, Inc. stock may see a shift in April 2026. The expected range spans $6.57–$9.76, with an average target of $7.94. This represents a positive outlook and a possible gain of +56.30%.
May 2026
Analyzing established trends, Myriad Genetics, Inc. looks set to move in May 2026. Projections place the stock between $7.39 and $12.65, averaging around $10.30. This suggests a +102.76% gain from current levels.
June 2026
Market indicators suggest Myriad Genetics, Inc. could experience notable changes during June 2026. Prices could fluctuate within $7.89 to $13.22, with a midpoint forecast of $11.81. The stock might deliver a +132.48% gain.
July 2026
Forecasting for July 2026, models estimate that Myriad Genetics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.94 and $16.21, averaging $12.93. This signals a positive trajectory with potential returns around +154.53%.
August 2026
According to our latest forecast models, Myriad Genetics, Inc. (MYGN) is positioned to show a strong performance in August 2026. The price is predicted to move between $7.71 and $17.63, settling at an average of $15.47. This could translate to a +204.53% gain.
September 2026
Based on current market signals, Myriad Genetics, Inc. is projected to trend september 2026. We forecast a trading range from $6.95 to $19.91, with a likely average price of $15.58. Investors could expect a potential return of +206.69%.
October 2026
Our predictive algorithms indicate Myriad Genetics, Inc. stock may see a shift in October 2026. The expected range spans $5.80–$24.03, with an average target of $18.13. This represents a positive outlook and a possible gain of +256.89%.
November 2026
Analyzing established trends, Myriad Genetics, Inc. looks set to move in November 2026. Projections place the stock between $2.90 and $23.57, averaging around $15.83. This suggests a +211.61% gain from current levels.
December 2026
Market indicators suggest Myriad Genetics, Inc. could experience notable changes during December 2026. Prices could fluctuate within $2.20 to $22.98, with a midpoint forecast of $15.42. The stock might deliver a +203.54% gain.
January 2027
Forecasting for January 2027, models estimate that Myriad Genetics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.26 and $24.27, averaging $15.49. This signals a positive trajectory with potential returns around +204.92%.
February 2027
According to our latest forecast models, Myriad Genetics, Inc. (MYGN) is positioned to show a strong performance in February 2027. The price is predicted to move between $1.02 and $21.71, settling at an average of $13.58. This could translate to a +167.32% gain.
MYGN's history of dividends and stock splits also plays a role in long-term investor confidence.